Table 2 Feasibility outcome measures comprising of completion and retention rates, session spread, difficulties faced and adverse events
Total | Home | Clinic | |
|---|---|---|---|
Completion and retention | |||
Treatment completion (at least 20 sessions) | 95% (19/20) | 95% (9/10) | 95% (9/10) |
Treatment completion (all 24 sessions) | 90% (18/20) | 95% (9/10) | 95% (9/10) |
Retention (post-intervention) | 100% (20/20) | 100% (10/10) | 100% (10/10) |
Session spread | |||
3 sessions/week throughout trial | 10% (2/20) | 10% (1/10) | 10% (1/10) |
More than 3 weeks of having 3 sessions/week | 75% (15/20) | 60% (6/10) | 90% (9/10) |
Technical issues | |||
Headband disconnectivity | 30% (6/20) | 30% (3/10) | 30% (3/10) |
Game application software hanging/crashing | 0% (0/20) | 0% (0/10) | 0% (0/10) |
Gameplay defect | 0% (0/20) | 0% (0/10) | 0% (0/10) |
Other difficulties | |||
Game set up by parentsa,b | – | 20% (2/10) | – |
Game set up by childa,b | – | 0% (0/10) | – |
Require parent supervisiona,b | – | 20% (2/10) | – |
Gameplayb | 25% (5/20) | 20% (2/10) | 30% (3/10) |
Adverse events | |||
Serious adverse events | 0 | 0 | 0 |
Sleep problems | 0 | 0 | 0 |
Somatic complaints | 5% (1/20) | 10% (1/10) | 0 |
Other complaintsc | 5% (1/20) | 0 | 10% (1/10) |